Financing Decisions and Capital Structure Dynamics in Cross-Border Acquisitions: A Case Study of an Indonesian Pharmaceutical Company
Downloads
dynamics in cross-border acquisitions undertaken by Indonesian pharmaceutical firms. Cross-border acquisitions in the pharmaceutical industry present high complexity and financial risk, yet limited research has explored how emerging market firms finance such transactions and manage post-acquisition capital structure adjustments. This research aims to analyze funding strategies, leverage changes, financial risk implications, and post-acquisition capital structure adjustments in Indonesian pharmaceutical companies. Using a multiple case study approach, the research evaluated three Indonesian pharmaceutical companies that conducted cross-border acquisitions in different countries, with analysis covering one year before to three years after the transaction. The findings reveal that funding strategies vary significantly across companies, ranging from internal funding to debt-based and combined debt-equity financing. Debt-based funding increases post-acquisition leverage and financial risk, potentially leading to financial distress in the short term, while internal funding maintains financial stability despite international expansion. The results also show that capital structures continue to undergo adjustments through deleveraging and cash flow optimization. The study contributes to the literature on financing decisions and capital structure in cross-border settings, particularly in the context of emerging markets and the highly regulated pharmaceutical industry, and offers practical recommendations for company management in designing balanced funding strategies between growth and financial stability.
Ali, A., Iram, W., & Alam, M. (2025). Financial globalization, entrepreneurship, and economic growth: Evidence from Asian countries. Journal of Social Signs Review, 3(7), 174–191.
Almeman, A. (2024). The digital transformation in pharmacy: Embracing online platforms and the cosmeceutical paradigm shift. Journal of Health, Population and Nutrition, 43(1), 60.
Bala, S., Garg, D., Sridhar, K., Inbaraj, B. S., Singh, R., Kamma, S., Tripathi, M., & Sharma, M. (2023). Transformation of agro-waste into value-added bioproducts and bioactive compounds: Micro/nano formulations and application in the agri-food-pharma sector. Bioengineering, 10(2), 152.
Brigham, E. F., & Houston, J. F. (2019). Fundamentals of financial management (15th ed.). Cengage Learning.
Cockburn, I. M. (2007). Is the pharmaceutical industry in a productivity crisis? Innovation Policy and the Economy, 7, 1–32.
Deloitte. (2023). 2023 global life sciences outlook: Reimagining life sciences in the decade ahead. Deloitte Insights.
Ebabu, E. A., Yu, H., Weikang, Z., Yixiong, H., & Ambelu, A. A. (2026). Navigating sustainable digital transformation in South-South cross-border e-commerce: Insights on cultural adaptation, green marketing strategy, and inclusive business model innovation. International Review of Economics & Finance, 104907.
Erel, I., Jang, Y., & Weisbach, M. S. (2022). Cross-border mergers and acquisitions. Journal of Finance, 77(3), 1469–1510.
Erel, I., Liao, R. C., & Weisbach, M. S. (2012). Determinants of cross-border mergers and acquisitions. Journal of Finance, 67(3), 1045–1082.
Golec, J. H., & Vernon, J. A. (2006). European pharmaceutical price regulation, firm profitability, and R&D spending (NBER Working Paper No. 12676). National Bureau of Economic Research.
Kormakova, I., Kruhlyanko, A., Peniuk, V., Ursakii, Y., & Verstiak, O. (2023). Actual strategies for businesses penetrating foreign markets in the modern economy: Globalisation aspect. International Journal of Professional Business Review, 8(5), 117.
Martynova, M., & Renneboog, L. (2009). What determines the financing decision in corporate takeovers: Cost of capital, agency problems, or the means of payment? Journal of Corporate Finance, 15(3), 290–315.
OECD. (2021). Pharmaceutical innovation and access to medicines. OECD Publishing.
Ozalp, H., Ozcan, P., Dinckol, D., Zachariadis, M., & Gawer, A. (2022). “Digital colonization” of highly regulated industries: An analysis of big tech platforms’ entry into health care and education. California Management Review, 64(4), 78–107.
PwC. (2022). Global pharma and life sciences deals insights: Year-end 2022. PwC.
Rajan, R. G., & Zingales, L. (1995). What do we know about capital structure? Some evidence from international data. Journal of Finance, 50(5), 1421–1460.
Shimizu, K., Hitt, M. A., Vaidyanath, D., & Pisano, V. (2004). Theoretical foundations of cross-border mergers and acquisitions: A review of current research and recommendations for the future. Journal of International Management, 10(3), 307–353.
Tariq, M. U. (2025). Strategic place marketing in cross-border regions: Enhancing territorial cooperation and economic growth. In Cross-border regions cooperation and implications for organizations (pp. 107–136). IGI Global Scientific Publishing.
Teece, D. J. (2022). A wider-aperture lens for global strategic management: The multinational enterprise in a bifurcated global economy. Global Strategy Journal, 12(3), 488–519.
UNCTAD. (2023). World investment report 2023. United Nations.
World Bank. (2022). Global economic prospects. World Bank.
Yang, W., & Zhao, K. (2024). Cross-border capital flows and low-carbon economic development: Examining the impact of foreign shareholding. International Review of Financial Analysis, 96, 103652.
Yin, R. K. (2018). Case study research and applications: Design and methods (6th ed.). SAGE Publications.
Zahra, S. A., & Hashai, N. (2025). Contemporary transitions in the international activities of startups and their policy implications. Journal of International Business Policy, 8(4), 391–405.
Copyright (c) 2026 Sugianto Sugianto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
